Stereotaxis Inc (STXS): Kapitalisasi marang pendapatan

Simbol lan logo merek Stereotaxis Inc (STXS)

Limited clinic budgets and marketing expenses are slowing the path to profitability for Stereotaxis, Inc. (STXS). The revenue multiple trend visualizes the market valuation, where the 2.70 metric confirms the current level. Its monopoly status in magnetic navigation allows Stereotaxis, Inc. (STXS) to maintain pricing power. Additional growth potential lies in the recurring sales of disposable catheters, which create a scalable stream of high-margin revenue.

STXS Multiplikator P/S Stereotaxis Inc (04.07.2022 - 13.11.2026)

Rincian analitis perusahaan Stereotaxis Corp (STXS)

- rega saham lan konsensus proyeksi valuasi:
Analisis umum perusahaan:STXS stereotaxis.com
Barang utama Stereotaxis, Inc.

The P/S ratio determines the market value of a business per unit of generated revenue, making it possible to identify whether an asset is overvalued relative to its actual sales. By analyzing the median P/S, an investor can assess the monetization efficiency of the robotic cardiology systems of Stereotaxis, Inc. (STXS), where high equipment precision and adherence to ESG principles create long-term potential for capitalization growth alongside the optimization of production costs.

Pesaing Stereotaxis, Inc.

BSX (bostonscientific.com) - Rasio kapitalisasi pasar marang pendapatan|Rasio rega marang pendapatan Edwards Lifesciences Corporation EW|RMD - Kapitalisasi marang pendapatan|OmniPod - Multiplikator P/S|Rega marang dodolan Zimmer Biomet Holdings|COO: Multiplikator P/S|Rasio kapitalisasi marang pendapatan ALGN|GMED (Globus Medical) - Multiplikator P/S|TransMedics Group Inc (TMDX) - Koefisien rega marang pendapatan|Multiplikator P/S ATEC|Kapitalisasi marang pendapatan Artivion Corp AORT|Multiplikator P/S ENOV (Enovis Corporation)|Multiplikator P/S integralife.com IART|ESTA - Rasio rega marang pendapatan|BBNX: Rasio rega marang pendapatan|IRMD (Iradimed) - Kapitalisasi marang pendapatan|Embecta Health - Rasio kapitalisasi pasar marang pendapatan|TNDM (Tandem Diabetes Care) - Multiplikator P/S|Rega marang dodolan axogeninc.com AXGN|Rasio rega marang pendapatan SI-BONE (SIBN)|Orthofix Medical (OFIX) - Multiplikator rega marang pendapatan|Bioventus Corp - Kapitalisasi marang pendapatan|Multiplikator P/S OrthoPediatrics Corp KIDS|Treace Medical Concepts - Multiplikator P/S|Koefisien rega marang pendapatan blade.com SRTA|Carlsmed (CARL) - Rasio rega marang pendapatan|Rasio rega marang dodolan RXST (RxSight Inc)|Rasio rega marang pendapatan ClearPoint Neuro Inc.|Kapitalisasi marang pendapatan Neuronetics, Inc (STIM)|Multiplikator P/S SGHT|OBIO - Rega marang dodolan|Rasio rega marang pendapatan Anika Therapeutics, Inc. ANIK|NSPR: Rasio kapitalisasi marang pendapatan|ZJYL: Kapitalisasi marang pendapatan|Vivani Medical, Inc. - Kapitalisasi marang volume dodolan|xtantmedical.com (XTNT) - Rasio rega marang pendapatan|NMTC - Koefisien rega marang pendapatan|Kapitalisasi marang pendapatan MODD|MYO (Myomo Inc.) - Kapitalisasi marang volume dodolan|Multiplikator P/S COCH|VVOS - Rega marang dodolan|Rasio rega marang pendapatan enVVeno Medical NVNO|Rasio kapitalisasi pasar marang pendapatan SINT|Tenon Medical - Multiplikator P/S|Rega marang dodolan ReWalk Robotics|autonomix.com (AMIX) - Rasio rega marang pendapatan|Rega marang dodolan INVO Fertility Corp (IVF)|Kapitalisasi marang pendapatan BBLG|AXNX (axonics.com) - Kapitalisasi marang volume dodolan|Multiplikator P/S BIOL|Multiplikator P/S dynatronics.com (DYNT)|Paragon 28 - Kapitalisasi marang pendapatan|INVO: Rasio kapitalisasi marang pendapatan